Glenmark Pharmaceuticals s.r.o. Synoptis Industrial Sp. z o.o.
PolandAll drugs from this manufacturer
-
This is a medicine used in the treatment of chronic asthma in adults, adolescents, and children over 12 years of age. It helps to facilitate breathing by reducing the severity of symptoms and the risk of an asthma attack.
Dosage form: solution, inhalation spray
Active substance Dosage ciclesonide 0.1 mg ATC: R03BA08
-
CYXEZON is used for the treatment of chronic asthma in adults, adolescents, and children aged 12 years and older. It helps to make breathing easier by reducing the severity of symptoms and the risk of asthma attacks.
Dosage form: solution, inhalation spray
Active substance Dosage ciclesonide 0.2 mg/dose ATC: R03BA08
-
LERHASA is used in adults, adolescents, and children (from 4 to 11 years old) to treat breathing disorders related to asthma and similar conditions (e.g., chronic bronchitis, emphysema) and to prevent asthma symptoms triggered by physical exertion or factors such as dust, pollen, pet dander, or cigarette smoke.
Dosage form: aerosol, inhalation suspension
Active substance Dosage salbutamol 0.1205 mg ATC: R03AC02
-
The medicine is used to prevent asthma symptoms. It has anti-inflammatory effects, reducing swelling and irritation of the airways, which makes breathing easier.
Dosage form: solution, inhalation spray
Active substance Dosage beclometasone dipropionate 100 mcg ATC: R03BA01
-
The medicine is used to prevent asthma symptoms. It has anti-inflammatory effects, reducing swelling and irritation in the airways, which makes breathing easier.
Dosage form: solution, inhalation spray
Active substance Dosage beclometasone dipropionate 200 mcg ATC: R03BA01
-
It is used to treat adults as well as children and adolescents (over 10 years of age) with relapsing-remitting multiple sclerosis. It helps protect the nervous system by reducing inflammation.
Dosage form: tablets, film-coated
Active substance Dosage teriflunomide 14 mg ATC: L04AA31